Request Appointment
160 E 53rd StNew York, NY 10022
Overview of Dr. Cytryn
Dr. Samuel Cytryn is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and NYC Health + Hospitals / Bellevue. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 9 years. He is one of 527 doctors at Memorial Sloan Kettering Cancer Center and one of 66 doctors at NYC Health + Hospitals / Bellevue who specialize in Oncology. He has more than 10 publications and over 100 citings.
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 2017 - 2020
Icahn School of Medicine at Mount SinaiClass of 2017
Certifications & Licensure
NJ State Medical License 2024 - 2027
CT State Medical License 2024 - 2026
NY State Medical License 2019 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer Start of enrollment: 2024 Feb 01
Roles: Contact
Publications & Presentations
PubMed
- Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial.Yan-Juan Zhu, Xue-Song Chang, Xiao-Yu Wu, Wei Wang, De-Chang Diao
Journal of the National Cancer Institute. 2026-04-01 - Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.Samuel L Cytryn, Raktim Borpatragohain, Karmelina Charalambous, William Phu, Ronak Shah
JCO Precision Oncology. 2026-04-01 - Complementary Chinese Herbal Medicine Use and Gastrointestinal Cancers: A Scoping Review of Usage Patterns and Survival Outcomes in Taiwanese Population-Based Studies.Chun Sing Lam, Eunbin Kwag, Susan Chimonas, Samuel L Cytryn, Yen-Nien Hou
Current Oncology Reports. 2025-12-01
Press Mentions
Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual MeetingFebruary 24th, 2025
Bispecific Antibodies in Gastric Cancer: Big Questions but Bigger Potential?August 26th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:





